UPS has named the two newest members to be elected to the board of directors: Eva Boratto, chief financial officer and executive vice president of CVS Health; and Wayne Hewett, former chief executive of Klöckner Pentaplast Group and Arysta LifeScience Corporation.
Boratto and Hewett will join the board’s audit committee. Their appointments bring UPS’s total board membership to fifteen.
At CVS, Boratto oversees the company’s financial strategy and operations including accounting and financial reporting, investor relations, mergers and acquisitions, treasury and capital planning, investments, risk management, tax, budgeting and planning, and procurement. Prior to CVS, Boratto served for 20 years at Merck in executive roles with responsibilities ranging from reporting and planning to controller and investor relations. Prior to Merck, she was a financial analyst at Bristol-Myers Squibb.
Hewett serves as a senior advisor at private equity firm Permira; as non-executive chair of DiversiTech Corporation; and as non-executive chair of Cambrex Corporation. He spent two decades at General Electric in roles including vice president of supply chain and operations, president and chief executive of GE advanced materials and other senior executive positions. He is also a member of the board of directors at Wells Fargo and The Home Depot.
“We are thrilled to have Boratto and Hewett joining our board of directors,” said UPS chief executive Carol Tomé. “They each bring a unique set of skills to our board. Further, today’s appointment is a meaningful move in support of our commitment to diversity and inclusion.”
David Abney, UPS executive chair, added: “UPS has a robust process in place to identify and add talented leaders who will strengthen our board membership. In Boratto and Hewett, we are adding two seasoned executives with diverse, global perspectives and deep subject matter expertise to support our strategic growth imperatives.”
